A recent international study focused on immune checkpoint inhibitor treatment has shown that higher thymic health was associated with a 35% lower risk of cancer progression in a group of 1200 non-small cell lung cancer patients. While further validation of this finding is required, thymic health "could serve as a non-invasive biomarker of adaptive immune competence in a range of different cancers."
To learn more about this study, click here.
Source mentioned:
Abstract 108O - ‘Thymic health is associated with immunotherapy outcomes in patients with cancer ‘, presented by Dr Simon Bernatz during Proffered Paper session 1: Basic science & Translational research on Saturday, 18 October, from 10:15 to 11:45 (CEST) in Hall 5.2 (Nuremberg Auditorium)
No comments:
Post a Comment